NOXOPHARM LIMITED ORDINARY (NOX) Short Interest

Name: NOXOPHARM LIMITED ORDINARY (NOX) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

NOXOPHARM LIMITED ORDINARY (ASX:NOX) had 0.00% of shares reported as short positions as of 2 June 2026, representing 11,657 shares. NOXOPHARM LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.00%
Reported positions: 11,657
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 2 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

NOX

Noxopharm

Pharmaceuticals, Biotechnology & Life Sciences

Noxopharm Limited is an Australian clinical-stage drug development company focused on creating innovative treatments for cancer and cytokine release syndrome (septic shock). The company is dedicated to improving patient outcomes through novel therapies and has a pipeline of drug candidates targeting unmet medical needs in oncology and inflammation.

pharmaceuticals

biotechnology

cancer treatment

drug development

Shorted

short percentage0.00%

reported shorts11.7K

shares on issue292.238M